Precision BioSciences Inc Stock
Precision BioSciences Inc is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 55 € there is potential for a 15704.6% increase which would mean more than doubling the current price of 0.35 € for Precision BioSciences Inc.
Our community identified positive and negative aspects for Precision BioSciences Inc stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Precision BioSciences Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Precision BioSciences Inc in the next few years
Pros
?
B****
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Precision BioSciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Precision BioSciences Inc | - | - | - | - | - | - | - |
| Stoke Therapeutics Inc | 6.870% | 9.774% | 33.945% | 135.484% | 175.472% | - | - |
| Personalis Inc | -6.360% | -16.991% | 8.098% | 118.823% | 35.050% | 206.982% | -76.345% |
| Immuron | 1.910% | -37.008% | -41.176% | -56.284% | -51.220% | -57.447% | -86.325% |
Comments
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Show more
Ratings data for DTIL provided by MarketBeat
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Show more
Ratings data for DTIL provided by MarketBeat
Precision BioSciences, Inc. (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Show more
Ratings data for DTIL provided by MarketBeat

